274 related articles for article (PubMed ID: 36570537)
1. The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease.
Clark C; Rabl M; Dayon L; Popp J
Front Aging Neurosci; 2022; 14():1065904. PubMed ID: 36570537
[TBL] [Abstract][Full Text] [Related]
2. An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease.
Clark C; Dayon L; Masoodi M; Bowman GL; Popp J
Alzheimers Res Ther; 2021 Apr; 13(1):71. PubMed ID: 33794997
[TBL] [Abstract][Full Text] [Related]
3. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F
Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136
[TBL] [Abstract][Full Text] [Related]
4. Spatial Multi-Omics in Alzheimer's Disease: A Multi-Dimensional Approach to Understanding Pathology and Progression.
Ma Y; Shi W; Dong Y; Sun Y; Jin Q
Curr Issues Mol Biol; 2024 May; 46(5):4968-4990. PubMed ID: 38785566
[TBL] [Abstract][Full Text] [Related]
5. Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence.
Hampel H; Nisticò R; Seyfried NT; Levey AI; Modeste E; Lemercier P; Baldacci F; Toschi N; Garaci F; Perry G; Emanuele E; Valenzuela PL; Lucia A; Urbani A; Sancesario GM; Mapstone M; Corbo M; Vergallo A; Lista S;
Ageing Res Rev; 2021 Aug; 69():101346. PubMed ID: 33915266
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis, therapeutic strategies and biomarker development based on "omics" analysis related to microglia in Alzheimer's disease.
Gao C; Shen X; Tan Y; Chen S
J Neuroinflammation; 2022 Sep; 19(1):215. PubMed ID: 36058959
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the Molecular Footprint: Proteome-Based Biomarkers for Alzheimer's Disease.
Jain M; Dhariwal R; Patil N; Ojha S; Tendulkar R; Tendulkar M; Dhanda PS; Yadav A; Kaushik P
Proteomes; 2023 Oct; 11(4):. PubMed ID: 37873875
[TBL] [Abstract][Full Text] [Related]
8. Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision Medicine.
Ghosh D; Bernstein JA; Khurana Hershey GK; Rothenberg ME; Mersha TB
Front Immunol; 2018; 9():2727. PubMed ID: 30631320
[TBL] [Abstract][Full Text] [Related]
9. Omics-based biomarkers discovery for Alzheimer's disease.
Aerqin Q; Wang ZT; Wu KM; He XY; Dong Q; Yu JT
Cell Mol Life Sci; 2022 Nov; 79(12):585. PubMed ID: 36348101
[TBL] [Abstract][Full Text] [Related]
10. Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing.
Fang J; Pieper AA; Nussinov R; Lee G; Bekris L; Leverenz JB; Cummings J; Cheng F
Med Res Rev; 2020 Nov; 40(6):2386-2426. PubMed ID: 32656864
[TBL] [Abstract][Full Text] [Related]
11. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
Castrillo JI; Lista S; Hampel H; Ritchie CW
Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
[TBL] [Abstract][Full Text] [Related]
12. Precision pharmacology for Alzheimer's disease.
Hampel H; Vergallo A; Aguilar LF; Benda N; Broich K; Cuello AC; Cummings J; Dubois B; Federoff HJ; Fiandaca M; Genthon R; Haberkamp M; Karran E; Mapstone M; Perry G; Schneider LS; Welikovitch LA; Woodcock J; Baldacci F; Lista S;
Pharmacol Res; 2018 Apr; 130():331-365. PubMed ID: 29458203
[TBL] [Abstract][Full Text] [Related]
13. Applied machine learning in Alzheimer's disease research: omics, imaging, and clinical data.
Li Z; Jiang X; Wang Y; Kim Y
Emerg Top Life Sci; 2021 Dec; 5(6):765-777. PubMed ID: 34881778
[TBL] [Abstract][Full Text] [Related]
14. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
[TBL] [Abstract][Full Text] [Related]
15. Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer's disease.
Eteleeb AM; Novotny BC; Tarraga CS; Sohn C; Dhungel E; Brase L; Nallapu A; Buss J; Farias F; Bergmann K; Bradley J; Norton J; Gentsch J; Wang F; Davis AA; Morris JC; Karch CM; Perrin RJ; Benitez BA; Harari O
PLoS Biol; 2024 Apr; 22(4):e3002607. PubMed ID: 38687811
[TBL] [Abstract][Full Text] [Related]
16. Untangling Alzheimer's disease with spatial multi-omics: a brief review.
Marshall CR; Farrow MA; Djambazova KV; Spraggins JM
Front Aging Neurosci; 2023; 15():1150512. PubMed ID: 37533766
[TBL] [Abstract][Full Text] [Related]
17. Integrated analyses of brain and platelet omics reveal their common altered and driven molecules in Alzheimer's disease.
Yu H; Li M; Pan Q; Liu Y; Zhang Y; He T; Yang H; Xiao Y; Weng Y; Gao Y; Ke D; Chai G; Wang JZ
MedComm (2020); 2022 Dec; 3(4):e180. PubMed ID: 36254251
[TBL] [Abstract][Full Text] [Related]
18. A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: Statistical approach vs machine learning approach.
Tan MS; Cheah PL; Chin AV; Looi LM; Chang SW
Comput Biol Med; 2021 Dec; 139():104947. PubMed ID: 34678481
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer's Disease.
Hadjidemetriou M; Rivers-Auty J; Papafilippou L; Eales J; Kellett KAB; Hooper NM; Lawrence CB; Kostarelos K
ACS Nano; 2021 Apr; 15(4):7357-7369. PubMed ID: 33730479
[TBL] [Abstract][Full Text] [Related]
20. Computational approaches for network-based integrative multi-omics analysis.
Agamah FE; Bayjanov JR; Niehues A; Njoku KF; Skelton M; Mazandu GK; Ederveen THA; Mulder N; Chimusa ER; 't Hoen PAC
Front Mol Biosci; 2022; 9():967205. PubMed ID: 36452456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
